VIZZ FDA approval date

The FDA approved VIZZ on 31 Jul 2025.

FDA approval date
31 Jul 2025

Drug identity has not yet been verified against registry records

Also recorded as ACECLIDINE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-07-31DayVIZZFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA218585", "applicant_as_listed_by_fda": "LENZ THERAP", "brand_names": ["VIZZ"], "active_ingredients": ["ACECLIDINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250731", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026